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Abstract
Several clinically used drugs are mitotoxic causing mitochondrial DNA (mtDNA) variations,
and thereby influence cancer treatment response. We hypothesized that radiation respon-
siveness will be enhanced in cellular models with decreased mtDNA content, attributed to
altered reactive oxygen species (ROS) production and antioxidant capacity. For this pur-
pose BEAS-2B, A549, and 143B cell lines were depleted from their mtDNA (ρ0). Overall sur-
vival after irradiation was increased (p<0.001) for BEAS-2B ρ0 cells, while decreased for
both tumor ρ0 lines (p<0.05). In agreement, increased residual DNA damage was observed
after mtDNA depletion for A549 and 143B cells. Intrinsic radiosensitivity (surviving fraction
at 2Gy) was not influenced. We investigated whether ROS levels, oxidative stress and/or
antioxidant responses were responsible for altered radiation responses. Baseline ROS for-
mation was similar between BEAS-2B parental and ρ0 cells, while reduced in A549 and
143B ρ0 cells, compared to their parental counterparts. After irradiation, ROS levels signifi-
cantly increased for all parental cell lines, while levels for ρ0 cells remained unchanged. In
order to investigate the presence of oxidative stress upon irradiation reduced glutathione:
oxidized glutathione (GSH:GSSG) ratios were determined. Irradiation reduced GSH:GSSG
ratios for BEAS-2B parental and 143B ρ0, while for A549 this ratio remained equal. Addition-
ally, changes in antioxidant responses were observed. Our results indicate that mtDNA
depletion results in varying radiation responses potentially involving variations in cellular
ROS and antioxidant defence mechanisms. We therefore suggest when mitotoxic drugs are
combined with radiation, in particular at high dose per fraction, the effect of these drugs on
mtDNA copy number should be explored.
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Introduction
Under normal physiological conditions, mitochondria are important organelles in the cell.
One of their key functions is the production of adenosine triphosphate (ATP) via the oxida-
tive phosphorylation system (OXPHOS), thereby providing the cell with its essential energy
supply. It has been observed that tumor cells rely less on OXPHOS but are more dependent
on aerobic glycolysis, also known as the Warburg effect [1]. New findings have revealed that
this metabolic shift could be the result of metabolic reprogramming from a more OXPHOS
to a more glycolytic phenotype (uncoupled glycolysis) regardless of oxygen presence in the
tumor tissue, supporting the tumor’s anabolic growth and micro-environmental adaptations.
This may be a possible explanation for an increased metastatic potential of tumor cells [2,3].
Potential causes for such metabolic reprogramming could be changes in the mitochondrial
genome (mtDNA) such as deletions, substitutions and even mtDNA copy number varia-
tions, leading to dysfunctional mitochondria [4]. Mitochondria play an important role in
processes like reactive oxygen production, redox signalling and apoptosis, while these pro-
cesses influence significantly radiotherapy (RT) response [5,6,7,8]. Furthermore, repair of
RT-induced damage is dependent on mitochondrial energy supply which heavily relies upon
the functionality of mitochondria [9]. mtDNA alterations, such as mutations, deletions or
copy number variations, may therefore influence RT response. These variations can be
potentially caused by mitotoxic agents, such as cisplatin [10] or doxorubicin [11]. Cisplatin
is able to induce a decrease in mtDNA copy number and impairment of mtRNA synthesis
[10]. Doxorubicin intercalates with mtDNA and thereby contributes to mitochondrial toxic-
ity [11]. Different types of alterations of the mtDNA genome have been found to be related
to cancer and treatment outcome [4]. Cells fully depleted from their mitochondrial genome,
Rho-0 (ρ0) cells, are an extreme in vitro model to investigate the association between radia-
tion outcome and dysfunctional mitochondria due to abnormalities in the mitochondrial
genome [12,13]. Several contradictory results on cellular mtDNA depletion using various
(tumor) cell lines have been published. Different radiation responses were observed varying
between a radioresistant phenotype to no difference in radiation response in vitro [14,15].
However, an increased radiation response was observed in an in vivo model [16]. To our
knowledge no mechanistic insights have been proposed to explain the observed differences
in radiation response of mtDNA depleted cell lines. Therefore, the aim of this study was to
elicudate the mechanistic insights underlying the radiation response of mtDNA depleted
cells. We hypothesized that reduced mitochondrial function after mtDNA depletion changes
the radiation response and this is dependent on altered ATP production, ROS production
and on the cells’ antioxidant capacity.
Material and methods
Cell culture model
The parental 143B and mtDNA depleted 143B Rho-0 (ρ0) osteosarcoma cells were cultured
in Gibco’s Dulbecco’s modified Eagle’s medium (DMEM, D-glucose 4.5 g/l) with 10% fetal
bovine serum (FBS; Lonza), the latter supplemented with 150 μg/ml uridine and 100 μg/ml
bromodeoxyuridine (Sigma-Aldrich) [17]. A549 (alveolar type-II carcinoma cells) ρ0 cells
were created by Prof. Dr. Ian Holt (Cambridge University, United Kingdom) and parental and
ρ0 cells were kindly provided by Dr. Lodovica Vergani (Padova University, Italy). mtDNA
depletion of BEAS-2B (adenovirus-12 SV40 hybrid virus transformed bronchial epithelial)
cells was accomplished by culturing cells in medium supplemented with ethidium bromide
(50 ng/ml; Sigma-Aldrich). Both A549 and BEAS-2B cells were cultured in DMEM (D-glucose
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4.5 g/l) supplemented with 25% FBS, vitamins, 1X essential and non-essential amino acids
(Sigma-Aldrich) and 50 μg/ml uridine (Acros Organics).
mtDNA copy number determination
Confirmation of mtDNA depletion was obtained by performing quantitive PCR. DNA was
isolated using the gentra puregene kit (Qiagen). Ratios for the nuclear DNA (nDNA) the B2M
gene and mitochondrial DNA (mtDNA) D-Loop were obtained in order to determine the
mtDNA content. Primer secquences can be found in S1 Table. Quantitative PCR was per-
formed on the 7900HT Fast Real-Time PCR System (Applied Biosystems). The PCR mixture
contained 5ng/μl DNA, 0.3 μM forward and reverse primer and 1x master-mix (SensiMix
SYBR1 HiRox kit, Bioline Reagents). The cycling conditions were: 20 50˚C, 10’ 95˚C, 40 cycles
of 1500 at 95˚C + 10 60˚C.
Proliferation and clonogenic survival assay
Proliferation was monitored during 7 days using the IncuCyte FLR after seeding 2500 cells/
well. For clonogenic survival analysis, cells were seeded on day 0 and irradiated using a 225kV
Philips X-ray tube on day 1. Subsequently, cells were trypsinized and plated in triplicate for
clonogenic survival. Cells were allowed to form colonies during 10 days, fixed and stained with
a 0.4% methylene blue (Sigma-Aldrich) in 70% ethanol solution. Colonies were defined as>50
cells [18].
Metabolic profiling
Cells were seeded at an optimized cell density of 3x104 cells/well (BEAS-2B) or 1.5x104 cells/
well (143B and A549). Metabolic profiles were generated by replacing the growth media for
assay media 1 hour before using the Seahorse XF96 extracellular Flux analyzer (Seahorse Bio-
science) according to manufacturer’s guidelines [19,20]. A mitochondrial stress test was estab-
lished measuring the oxygen consumption rate (OCR) after subsequent injections of 1 μM
oligomycin, optimized FCCP concentrations 0.3 μM (A549), 0.5 μM (143B) or 0.6 μM (BEAS-
2B) and 1 μM mixture of rotenone and antimycin A (Sigma-Aldrich) and spare capacity, pro-
ton leak and ATP production were calculated according to the Seahorse Bioscience guidelines.
The glycolysis stress test was performed by measuring the extracellular acidification rate
(ECAR) after sequential addition of 10 mM glucose, optimized oligomycin concentration
1.0 μM (all cell lines) and 0.1 M 2-deoxyglucose (2-DG) (Sigma-Aldrich). Calculations of the
glucose metabolism and glycolytic reserve were done according to the Seahorse Bioscience
guidelines. Baseline OCR or ECAR was determined prior to the first compound injection
using a mixing period of 5 minutes and a measurement period of 3 minutes followed by 3
loops of mixing and measuring for 3 minutes each. Every injection was followed by the same
measurement protocol of a mixing period of 5 minutes and a measurement period of 3 min-
utes followed by 3 loops of mixing and measuring for 3 minutes.
Molecular assays
ATP levels were measured based on the Cell-TiterGlo Luminescent cell viability test (Pro-
mega) on the Glomax 96 well luminometer (Promega). Levels of extracellular L-Lactic acid
were measured by using the L-lactic acid kit (Biosentec) according to manufacturer’s guide-
lines. Both ATP and L-lactic acid levels were corrected for cell counts. Formation of reactive
oxygen species (ROS) was detected 24 hours after ionizing radiation (4Gy). Cells were exposed
for 1 hour to 20 μM dihydrorhodamine 123 (Invitrogen) and subsequently washed with PBS
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before trypsinization and cell straining in order to obtain a single cell suspension. The cell sus-
pensions were exposed to 2 μg/ml final concentration of propidium iodide (Sigma-Aldrich) 1
minute before FACS analysis. Levels of ROS were determined in the propidium iodide nega-
tive population by flow cytometry (BD FACS Canto II) and expressed using mean fluorescent
intensity [21]. Glutathione levels (GSH and GSSG) were measured in the cell lysates as
described previously [22].
γ-H2AX immunocytochemistry
Cells were fixed with 100% methanol at −20˚C. Subsequently cells were permeabilized with
0.05% Tween-PBS and normal goat serum was used as blocking agent. Cells were stained with
a primairy anti-phospho(Ser139)-H2AX antibody (1:500, Millipore) followed by anti-rabbit
Alexa Fluor 488 (1:500, Invitrogen) as secundairy antibody. Hoechst 33342 (20 ug/ml, Sigma–
Aldrich) was used as nuclear counter stain. Images were acquired using a Leica TCS SPE con-
focal microscope.
RNA isolation and quantitative PCR analysis
mRNA was extracted using the NucleoSpin RNA II kit (Bioke) using iScript cDNA Synthesis
Kit (BioRad). Both methods were performed according to the manufacturers’ instructions.
Quantitative PCR was performed on the CFX96 (Biorad). The abundance of the genes of inter-
est were detected with SYBR1 Green I (Eurogentec). Values for each gene were normalized to
18S expression levels. Primer sequences are listed in the S1 Table.
Statistics
All statistical analyses were performed with GraphPad Prism version 5.03 for Windows
(GraphPad Software, 2009, California, USA). A non-parametric Mann–Whitney U test for
small groups was used to determine the statistical significance of differences between two inde-
pendent groups of variables. Clonogenic survival curves were compared using an extra sum F-
test. For all tests, a p<0.05 was considered significant.
Results
To investigate if extreme changes in OXPHOS capacity affect radiosensitivity, we used ρ0 cell
lines with different genetic backgrounds. All our ρ0 cell lines showed a strong and significant
decrease in mtDNA copy number (Fig 1A; BEAS-2B p<0.001; A549 p<0.05; 143B p<0.05).
Additionally, proliferation was decreased as evaluated by an increased doubling time (on aver-
age 54%) for all ρ0 cell lines (Fig 1A). We confirmed the drastic effect on OXPHOS upon
mtDNA depletion as basal respiration was almost absent (p<0.05) in the BEAS-2B, A549
and 143B ρ0 (Fig 1B) while the parental cells had a functional OXPHOS system with spare
capacity (Fig 1C). To compensate their loss of OXPHOS function, ρ0 cells showed an enhanced
(p<0.05) glucose metabolism accompanied with a loss in glycolytic reserve (Fig 1C; S1 Fig).
The mtDNA depletion did not result in reduced cellular ATP levels and no differences in lactic
acid production were observed between ρ0 and their parental counterparts (Fig 1D). Together
our results indicate that mtDNA depleted cells upscaled their glucose metabolism.
In order to assess the influence of mtDNA depletion on radiation response, clonogenic sur-
vival assays were performed. Overall survival was increased (p<0.001) for the BEAS-2B ρ0
cells, while decreased for A549 ρ0 (p<0.01) and 143B ρ0 (p<0.0001) cells (Fig 2A). However,
the intrinsic radiosensitivity assessed by the surviving fraction at 2Gy was not influenced
(p>0.05). No diffierences in initial DNA damage were observed shortly after irradiation
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between mtDNA depleted and parental cells. However, changes in residual DNA damage 24
hours after 4Gy irradiation were found between both cell lines in line with the clonogenic sur-
vival data. An increased number of residual γH2AX foci was observed for the 143B ρ0 and to a
lesser extent for the A549 ρ0 cells. The opposite was observed for the BEAS-2B, where the ρ0
cells showed a lower residual signal compared to the parental cell line (Fig 2B and S2 Fig).
Radiation therapy relies on the production of reactive oxygen species (ROS) for its lethal
properties. Additionally, cellular mitochondrial function plays an important role in ROS pro-
duction and redox signaling. Here we assessed ROS formation (Fig 3A) at baseline (0Gy),
which was found to be similar (p = 0.878) for BEAS-2B parental and ρ0 cell lines, while reduced
for A549 (NS) and 143B (p = 0.0211) ρ0 cells. ROS levels were significantly increased (p<0.05)
for all parental cell lines 24 hours after irradiation, while levels for the ρ0 cell lines remained
equal. ROS formation 24 hours after irradiation was significantly lower (p<0.05) for the the
A459 and 143B ρ0 cell lines compared to their parentals. Since “oxidative stress” indicates a
disbalance between ROS and antioxidants in favor for ROS, we investigated the antioxidant
capacity of the ρ0 cell lines using the ratio of GSH:GSSG as a proxy to assess if ROS scavenging
Fig 1. Validation of mtDNA depleted cell lines. A. qPCR assessed mtDNA copy number levels expressed in
percentage normalized to each parental (left panel) and the doubling time for all investigated cell lines (right panel). B.
Basal respiration expressed as oxygen consumption rate (OCR) in function of time (minutes). C. Stacked plot of
mitochondrial (left panel) or glycolysis (right panel) stress test after measuring OCR or extracellular acidification rate
(ECAR) respectively. D. Relative ATP levels in A.U. corrected for cell number (left panel) and L-Lactic acid levels in g/l
corrected for cell number (right panel). Data represent the mean ± SEM from at least 3 independent biological
experiments. * p<0.05, *** p<0.001.
https://doi.org/10.1371/journal.pone.0182508.g001
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mechanisms were altered. GSH:GSSG ratios were decreased for the BEAS-2B parental and
143B ρ0 cells upon irradiation. No alterations were observed for both A549 cell lines (Fig 3B).
The kelch-like ECH-associated protein 1 (Keap1)—Nuclear factor erythroid 2 (NF-E2)-related
factor 2 (Nrf2) pathway is an important oxidative stress response regulator and down-stream
targets of Nrf2 are found to be involved in NADPH production, glutathione metabolism and
utilization [23]. KEAP1mRNA levels were elevated for both tumor ρ0 cell lines at baseline and
after irradiation compared to their parentals (Fig 3C). mRNA expression levels of NRF2were
not significantly altered. Certain downstream targets of the Keap1-Nrf2 pathway such as the
malic enzyme 1 (ME1), involved in NADPH production, displayed elevated mRNA levels in
Fig 2. Radiation response in mtDNA depleted cell lines. A. Clonogenic survival plots, fitted according to the LQ
model. Results show mean ± SEM from at least 3 independent biological replicates. 0 Gy conditions are sham
irradiated. B. Representative merged fluorescent images of γH2AX foci (green) and nuclei (blue) visualizing residual
foci upon irradiation.
https://doi.org/10.1371/journal.pone.0182508.g002
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the tumor ρ0 cell lines (S3 Fig) while other targets such as glucose-6-phosphate dehydrogenase
(G6PD), phosphogluconate dehydrogenase (PGD), NAD(P)H quinone dehydrogenase 1
(NQO1, involved in quinone detoxification) and glutathione peroxidase 1 (GPX1) did not
show altered mRNA expression levels for the ρ0 cells (S3 Fig). Baseline levels of the antioxidant
superoxide dismutase 2 (SOD2,MnSOD) were elevated in the ρ0 cells (Fig 3C), being signifi-
cant for A549 (p = 0.0493). Irradiation increased SOD2 expression for both parental A549
(p<0.05) and ρ0 (NS; p = 0.0519) cells. On the other hand, SOD2 expression levels were
decreased upon irradiation for 143B parental cells (p = 0.0093). Irradiation did not alter SOD2
expression levels for the 143B ρ0 cells (p = 0.5476) neither for both BEAS-2B cell lines. Expres-
sion levels of superoxide dismutase 1 (SOD1, CuZnSOD) were not significantly altered upon
irradiation for the BEAS-2B, A549 and 143B cells (S3 Fig).
Discussion
Recently, mitochondrial DNA (mtDNA) variations have been linked to a wide variety of can-
cers and cancer outcome through influencing mitochondrial pathways [4] and may explain
the hampered cellular bioenergetics found in many cancer types. Mitochondrial dysfunction
has been found to be related to a chemoresistant phenotype in vitro [24,25,26,27] and
Fig 3. ROS and GSH levels at basal levels and 24 hours after 4Gy of irradiation. A. ROS levels
expressed in mean intensity at baseline and 24 hours after irradiation, relative to each parental celline at
baseline conditions. B. Ratio of GSH:GSSG levels at baseline and at 24 hours after irradiation for parental
and ρ0 cell lines. Data represents the mean ± SEM from at least 3 independent biological repeats. mtDNA
depleted cells are indicated by the dashed bars. * p<0.05. C. mRNA expression of KEAP1 and SOD2 24
hours after irradiation, normalized to each parental at baseline. Data represents the mean + SEM from at least
2 independent biological repeats. * p<0.05.
https://doi.org/10.1371/journal.pone.0182508.g003
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chemotherapeutic agents might be associated with a decreased mitochondrial function
[10,11,28]. Furthermore, several studies investigated the effect of mtDNA depletion with
respect to radiotherapy by using different (tumor) cell lines with contradictory results, from
a radioresistant phenotype or no difference in radiation response in vitro [14,15,29] to an
increased radiation response in vivo [16].
Reactive oxygen species (ROS) are formed in the presence of oxygen and are further
induced upon radiation resulting in DNA damage. Functional mitochondria are found to
be essential for radiation-induced ROS production [30]. Radiation causes either cell death
(mainly by mitotic catastrophy) or induces a sublethal DNA damage initiating a temporary
cell cycle arrest in order to repair the damage [4]. The interplay between mitochondrial func-
tion and radiation response is of great importance in such a radiation-induced DNA damage
repair [31]. As both ROS production and ATP are vital parameters for radiotherapy outcome
and mitochondrial function is essential for radiation-induced DNA repair, mtDNA variations
could alter the response to irradiation possibly via increased lactate production as a conse-
quence of a reduced oxidative phosphorylation system (OXPHOS) function [26,32]. Addition-
ally, it has been shown that Increased lactate results in a radioresistant phenotype [33].
However, in our study, no differences could be observed in cellular ATP levels for mtDNA
depleted cells, in agreement with the observed compensation by glycolysis induction often
found in cell lines with a dysfunctional OXPHOS system [34,35]. Although mtDNA depletion
resulted in a glycolytic phenotype, no elevated lactic acid production was observed. A possible
explanation for this finding could be that most lactic acid is catabolized in order to control the
intracellular pH of the cell [36,37].
We hypothesized that mtDNA depletion results in a more radiosensitive phenotype related
to altered ROS and ATP levels and changes in the antioxidant ROS scavaging capacity. Our
data showed, in line with literature, that a varying irradiation response occured in different cell
lines after mtDNA depletion. Overall, in our study the immortalized epithelial BEAS-2B ρ0 cell
line was less radiosensitive compared to the parental line, while the tumor derived ρ0 cell lines
(A549 and 143B) were more prone to a decreased survival upon radiation. However, the
intrinsic radiosensitivity, correlated to clinical outcome after conventional fractionated radio-
therapy and quantified by the survival fraction at 2Gy, was not significantly modified [38].
Residual γH2AX foci after irradiation were in agreement with the survival data, as described
previously [39]. Irradiation is able to elevate ROS levels [7]. In the parental cell lines used in
this study, the irradiation-induced increase in ROS levels was evident, while no increase was
observed in ρ0 cells. Potentially, this is due to the fact that both NADH ubiquinone oxidore-
ductase (CI) and ubiquinol-cytochrome c oxidoreductase (CIII), the major ROS generating
sites of the oxidative phosphorylation chain, might be deficient in the established ρ0 cells. This
may explain why we found relatively lower ROS levels in the ρ0 tumor cell lines [40,41,42]. In
contrast to the elevated ROS levels found in cells with mtDNA variations [26,43,44], Park et al.
demonstrated that ρ0 cells can also have normal ROS levels due to the protective up-regulation
of their antioxidant system during the ρ0 development [26].
Glutathione and SOD2 are important antioxidants that can be located in the mitochon-
drion [45]. Here we observed that the ratio between GSH and GSSG was decreased upon irra-
diation for the parental BEAS-2B and the 143B ρ0 cells, whearas no differences were found for
the A549 cells. These data suggest that differences in radiation response between parental and
mtDNA depleted cells could be determined by the antioxidant capacity of the cells. Superoxide
dismutase 2 (SOD2) is an antioxidant able to scavenge superoxide radicals in the mitochon-
drial matrix [46] and therefore can protect cells against radiation [47]. Cells with an overex-
pression of SOD2 are found to have a higher cell survival [47]. We indeed observed an
increase in SOD2 levels upon irradiation for the A549 parental cells. On the other hand,
Irradiation response in mtDNA depleted cells
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mitochondrial SOD2 levels where unaffected in the 143B cells. Previously, it has been reported
that ρ0 cells originating from different tissues can have altered glutathione antioxidant mecha-
nisms [48,49]. The Kelch-like ECH-associated protein 1- Nuclear factor erythroid 2 (NF-E2)-
related factor 2 (Keap1-Nrf2) pathway is an important oxidative stress response regulator and
downstream targets of Nrf2 are found to be involved in glutathione metabolism and utilization
[23,50]. KEAP1mRNA levels were found to be elevated for both tumor mtDNA depleted lines,
suggesting a role for this pathway in the antioxidant response. Some, but not all, downstream
targets of the Keap1-Nrf2 pathway were found to be elevated indicating that Keap1-Nrf2 could
play a role in the antioxidant capacity of ρ0, however this remains to be further elucidated. Fur-
thermore, it has also been suggested that variations in culture medium can influence oxidative
stress and oxidative stress responses, possibly explaining the observered differences in antioxi-
dant mechanisms [49,51]. A well-known example is cysteine, the precursor for glutathione
[51]. Therefore the use of glutathione and its effectors in culture medium should be carefully
considered when elucidating the interactions of mitochondrial function and antioxidants.
Taken together, mtDNA depletion resulted in decreased proliferation for all ρ0 cell lines,
increased clonogenic survival for the epithelial BEAS-2B cells, but reduced clonogenic survival
at higher irradiation doses for the tumor cell lines. Our findings indicate that inhibition of
OXPHOS might be useful to enhance radiotherapy effects, in particular for patients treated
with hypofractionated radiotherapy in rapidly proliferating tumors. This is in line with the
well-known OXPHOS inhibitor metformin, an U.S. food and drug administration (FDA)
approved drug for diabetes leading to an improvement of tumor oxygenation and better out-
come following radiotherapy [52,53]. Concluding, mtDNA depletion resulted in varying irra-
diation responses in different cell lines, potentially attributed to ROS and antioxidant capacity.
Additionally, the influence of mtDNA variations in normal tissue and tumor tissues should be
further elucidated in order to implement these novel findings in cancer treatment, both che-
motherapy as well as radiation therapy.
Supporting information
S1 Fig. Representative images of the glycolysis stress test for BEAS-2B, A549 and 143B.
Basal measurements are followed by subsequent injections of 10 mM glucose, 1.0 μM oligomy-
cin and 0.1 M 2-deoxyglucose.
(TIF)
S2 Fig. Quantification of representative images for γH2AX foci. γH2AX foci amount
(mean ± SEM) is shown at baseline and 24 hours after irradiation, relative to each cell line at
baseline conditions.
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S3 Fig. Expression of antioxidant genes. Data represents the mean ± SEM from at least 2
independent biological repeats, normalized to each parental line at baseline p<0.01.
(TIF)
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